Human immunity to fungal infections

Area of Science:

• Immunology
• Mycology
• Genetics

Background:

• Fungal infections (mycoses) pose a significant global health challenge, ranging from severe iatrogenic conditions to unexplained syndromes.
• Current antifungal drugs are insufficient, necessitating complementary strategies like enhancing host immunity.
• Understanding the molecular immunology of human susceptibility to fungi is crucial for distinguishing protective from harmful immune responses.

Purpose of the Study:

• To review the diversity of human intrinsic fungal susceptibility.
• To explore genetic and autoantibody-mediated factors influencing fungal disease outcomes.
• To highlight the importance of human models in understanding fungal immunology.

Main Methods:

• Review of existing literature on human fungal diseases.
• Analysis of genetic immunodeficiencies and population-specific genetic vulnerabilities.
• Examination of autoantibody-mediated immune responses in fungal infections.

Main Results:

• Human susceptibility to fungi varies significantly due to genetic factors and autoantibodies.
• Genetic immunodeficiencies and population-specific vulnerabilities reveal critical immune pathways.
• Human studies offer insights complementary to animal models and iatrogenic contexts.

Conclusions:

• A deeper understanding of human immunity to fungi is essential for developing effective treatments.
• Host-directed immunotherapies and public health interventions can be improved.
• This knowledge will advance precision medicine for managing fungal diseases.